Genome-wide association study of hepatitis C virus-and cryoglobulin-related vasculitis

Genes and Immunity

Volumn 15, Issue 7, 2014, Pages 500-505

  Zignego, A L ^a   Wojcik, G L ^b   Cacoub, P ^c,d,e   Visentini, M ^f   Casato, M ^f   Mangia, A ^g   Latanich, R ^h   Charles, E D ⁱ   Gragnani, L ^a   Terrier, B ^c   Piazzola, V ^g   Dustin, L B ^i,n   Khakoo, S I ^j   Busch, M P ^k   Lauer, G M ^l   Kim, A Y ^l   Alric, L ^m   Thomas, D L ^h   Duggal, P ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SORBONNE UNIVERSITÉ   (France)

^d Sorbonne Université   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^h DEPARTMENT OF PATHOLOGY   (United States)

ⁱ ROCKEFELLER UNIVERSITY   (United States)

^j UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^k BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

^m UNIVERSITÉ PAUL SABATIER   (France)

ⁿ UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; HLA DQA1 ANTIGEN; HLA DRB1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NOTCH4 RECEPTOR; VIRUS RNA; NOTCH RECEPTOR; NOTCH4 PROTEIN, HUMAN; ONCOPROTEIN;

ALLELE; ARTICLE; CHROMOSOME 6; CONTROLLED STUDY; CRYOGLOBULIN RELATED VASCULITIS; CRYOGLOBULINEMIA; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULITIS; CASE CONTROL STUDY; COMPLICATION; GENE; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 6; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; GENES, MHC CLASS II; GENOME-WIDE ASSOCIATION STUDY; HEPATITIS C; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RECEPTORS, NOTCH; VASCULITIS;

EID: 84908240957     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.41     Document Type: Article

References (41)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342.
2. Zignego AL, Giannini C, Monti M, Gragnani L. Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 2007; 39(Suppl 1): S38-S45.
3. Terrier B, Cacoub P. Cryoglobulinemia vasculitis: an update. Curr Opin Rheumatol 2013; 25: 10-18.
4. Zignego AL, Giannini C, Gragnani L. HCV and lymphoproliferation. Clin Dev Immunol 2012; 2012: 980942.
5. Monti G, Pioltelli P, Saccardo F, Campanini M, Candela M, Cavallero G et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 2005; 165: 101-105.
6. Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998; 160: 3594-3601.
7. Zignego AL, Gragnani L, Giannini C, Laffi G. The hepatitis C virus infection as a systemic disease. Intern Emerg Med 2012; 7(Suppl 3): S201-S208.
8. Ferri C, Zignego AL, Bombardieri S, La Civita L, Longombardo G, Monti M et al. Etiopathogenetic role of hepatitis C virus in mixed cryoglobulinemia, chronic liver diseases and lymphomas. Clin Exp Rheumatol 1995; 13(Suppl 13): S135-S140.
9. Cicardi M, Cesana B, Del Ninno E, Pappalardo E, Silini E, Agostoni A et al. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepat 2000; 7: 138-143.
10. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008; 3: 25.
11. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004; 33: 355-374.
12. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701-3704.
13. Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, Sollima S et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 2011; 10: 444-454.
14. Saadoun D, Asselah T, Resche-Rigon M, Charlotte F, Bedossa P, Valla D et al. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 2006; 43: 1337-1345.
15. De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 2012; 64: 843-853.
16. Cacoub P, Terrier B, Saadoun D. Hepatitis C virus-induced vasculitis: therapeutic options. Ann Rheum Dis 2014; 73: 24-30.
17. Dammacco F, Sansonno D. Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. New Engl J Med 2013; 369: 1035-1045.
18. Bianchettin G, Bonaccini C, Oliva R, Tramontano A, Cividini A, Casato M et al. Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemic patients and associated controls. J Virol 2007; 81: 4564-4571.
19. Invernizzi R, Nano R, Ippoliti G, Girino M, Gerzeli G. Cytochemical study of tetrahydrofolate dehydrogenase in chronic lymphocytic leukemia cells. Haematologica 1983; 68: 742-749.
20. Monti G, Saccardo F, Pioltelli P, Rinaldi G. The natural history of cryoglobulinemia: symptoms at onset and during follow-up. A report by the Italian Group for the Study of Cryoglobulinemias (GISC). Clin Exp Rheumatol 1995; 13(Suppl 13): S129-S133.
21. Lamprecht P, Gause A, Gross WL. Cryoglobulinemic vasculitis. Arthritis Rheum 1999; 42: 2507-2516.
22. Pozzato G, Burrone O, Baba K, Matsumoto M, Hijiiata M, Ota Y et al. Ethnic difference in the prevalence of monoclonal B-cell proliferation in patients affected by hepatitis C virus chronic liver disease. J Hepatol 1999; 30: 990-994.
23. Ossi E, Bordin MC, Businaro MA, Marson P, Bonadonna P, Chiaramonte M et al. HLA expression in type II mixed cryoglobulinemia and chronic hepatitis C virus. Clin Exp Rheumatol 1995; 13(Suppl 13): S91-S93.
24. Lenzi M, Frisoni M, Mantovani V, Ricci P, Muratori L, Francesconi R et al. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 1998; 91: 2062-2066.
25. Hwang SJ, Chu CW, Huang DF, Lan KH, Chang FY, Lee SD. Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C. Tissue Antigens 2002; 59: 31-37.
26. Amoroso A, Berrino M, Canale L, Cornaglia M, Guarrera S, Mazzola G et al. Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? J Hepatol 1998; 29: 36-44.
27. Cacoub P, Renou C, Kerr G, Hüe S, Rosenthal E, Cohen P et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 2001; 44: 2118-2124.
28. Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R et al. Genomewide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med 2013; 158: 235-245.
29. De Re V, Caggiari L, De Vita S, Mazzaro C, Lenzi M, Galli M et al. Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig Liver Dis 2007; 39(Suppl 1): S65-S71.
30. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y et al. Genomewide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010; 466: 113-117.
31. Tazi-Ahnini R, Cork MJ, Wengraf D, Wilson AG, Gawkrodger DJ, Birch MP et al. Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata. Hum Genet 2003; 112: 400-403.
32. Kochi Y, Yamada R, Kobayashi K, Takahashi A, Suzuki A, Sekine A et al. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences. Arthritis Rheum 2004; 50: 63-71.
33. Valdes AM, Thomson G, Consortium TDG. Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1. Diabetes Obes Metab 2009; 11(Suppl 1): 46-52.
34. Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, Auton A et al. Genes mirror geography within Europe. Nature 2008; 456: 98-101.
35. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
36. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-678.
37. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 2012; 44: 955-959.
38. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA et al. A map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061-1073.
39. Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010; 42: 436-440.
40. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007; 39: 906-913.
41. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.